Strategic Advice and Regulatory Analysis
BlueReg experienced consultants can provide insight into all regulatory requirements for France:
- Drug Registration
- Early Access Programmes
- Post Marketing Authorisation Application (MAA) activities
- Promotional material review
- Quality systems and audits
- Interactions with healthcare professionals includingcompliance with the French laws (DMOS, Transparence de liens, Charte de l’information promotionnelle)
- Pricing and reimbursement
The French system for preventing and managing shortages
The French regulation on the prevention and management of stock shortages of medicinal products is...
News - 28 May 2020
New Appointment to our Leadership Team !
BlueReg Group is delighted to announce the appointment of Dominique Patrone as General Manager of PharmaBlue....
News - 24 April 2020